awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q52633900-C415725E-C868-43BA-ADB1-0D190D90E997
Q52633900-C415725E-C868-43BA-ADB1-0D190D90E997
BestRank
Statement
http://www.wikidata.org/entity/statement/Q52633900-C415725E-C868-43BA-ADB1-0D190D90E997
Transitioning patients with immune thrombocytopenia to second-line therapy: Challenges and best practices.
P2860
Q52633900-C415725E-C868-43BA-ADB1-0D190D90E997
BestRank
Statement
http://www.wikidata.org/entity/statement/Q52633900-C415725E-C868-43BA-ADB1-0D190D90E997
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
15df3a423191daf21744f2becfcc9da94a9fa4ea
P2860
A multicenter randomized open-label study of rituximab plus rhTPO vs rituximab in corticosteroid-resistant or relapsed ITP.